Delving the Role of : An Edible Wild Plant to Mitigate the Biomarkers of Metabolic Syndrome
Overview
Endocrinology
Authors
Affiliations
Metabolic syndrome (MS), commonly known as syndrome X or insulin resistance syndrome, is a collection of risk factors for cardiovascular diseases and type II diabetes. MS is believed to impact over a billion individuals worldwide. It is a medical condition defined by visceral obesity, insulin resistance, high blood pressure, and abnormal cholesterol levels, according to the World Health Organization. The current dietary trends are more focused on the use of functional foods and nutraceuticals that are well known for their preventive and curative role against such pathological disorders. is one such medicinal plant that is gaining popularity. It is a wild, edible, succulent roadside shrub with cactus-like leaves. Besides its main nutrient contents, various bioactive constituents have been identified and linked with positive health outcomes of appetite-suppressing, hypolipidemic, antioxidant, hepatoprotective, and anticancer potentials. Hence, such properties make an invaluable plant against MS. The current review compiles recent available literature on nutritional composition, safety parameters, and therapeutic potential for MS. Summarized data in this review reveals that remains a neglected plant with limited food and therapeutic applications. Yet various studies explored here do prove its positive health-ameliorating outcomes.
Lone A, Bhat H, Kumar S, Ait-Kaddour A, Aadil R, Hassoun A Ultrason Sonochem. 2024; 112():107167.
PMID: 39616721 PMC: 11647646. DOI: 10.1016/j.ultsonch.2024.107167.
Gutierrez-Cuevas J, Lopez-Cifuentes D, Sandoval-Rodriguez A, Garcia-Banuelos J, Armendariz-Borunda J Pharmaceuticals (Basel). 2024; 17(7).
PMID: 39065815 PMC: 11280341. DOI: 10.3390/ph17070967.
Arif A, Sultan M, Nazir F, Ahmad K, Kashif M, Ahmad M Toxicol Res (Camb). 2024; 13(4):tfae094.
PMID: 38957782 PMC: 11214972. DOI: 10.1093/toxres/tfae094.
Natural products target glycolysis in liver disease.
Li S, Hao L, Hu X Front Pharmacol. 2023; 14:1242955.
PMID: 37663261 PMC: 10469892. DOI: 10.3389/fphar.2023.1242955.
Mora-Florez L, Cabrera-Rodriguez D, Hernandez-Carrion M Foods. 2023; 12(10).
PMID: 37238898 PMC: 10217312. DOI: 10.3390/foods12102080.